Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Current Deferred Revenue

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Current-Deferred-Revenue" stands at 18.63 Billion Japanese Yens as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -84.35 percent compared to the value the year prior.
The 1 year change in percent is -84.35.
The 3 year change in percent is -86.21.
The 5 year change in percent is -84.10.
The 10 year change in percent is -77.84.

The Serie's long term average value is 96.86 Billion Japanese Yens. It's latest available value, on 09/30/2024, is 80.77 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2024, is +1,281.97%.
The Serie's change in percent from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2024, is -90.20%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11